XML 64 R47.htm IDEA: XBRL DOCUMENT v3.24.0.1
Financial expenses, net (Tables)
12 Months Ended
Dec. 31, 2023
Schedule of Financial Expenses
 
 
 
 
 
 
 
 
 
 
 
 
 
    
Year ended December, 31
 
    
2023
    
2022
    
2021
 
    
(U.S. $ in millions)
 
Interest expenses and other bank charges
   $ 1,029      $ 930      $ 891  
(Income) loss from investments (1)
     (68      (10      90  
Foreign exchange (gains) losses, net
     30        (16      7  
Other, net (2)
     66        61        71  
    
 
 
    
 
 
    
 
 
 
Total finance expense, net
   $ 1,057      $ 966      $ 1,058  
    
 
 
    
 
 
    
 
 
 
 
(1)
Loss from investments in 2021 comprised mainly of revaluation gains and loss of Teva’s investment in American Well Corporation (“American Well”).
(2)
Amortization of issuance costs and terminated derivative instruments.